What is the duration of action of Actrapid (fast-acting insulin) in the body?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Action of Actrapid (Regular Insulin)

Actrapid (regular insulin) has an onset of action at 15 minutes, peaks at 3-4 hours, and has a total duration of action of 6-8 hours in the body. 1

Pharmacokinetic Profile

The complete time-action profile of Actrapid (regular insulin injection) is as follows:

  • Onset of action: 15 minutes after subcutaneous injection 1
  • Peak effect: 3-4 hours after administration 1
  • Duration of action: 6-8 hours total 1

Clinical Implications

Timing Considerations

The relatively slow onset and extended duration of Actrapid means it should ideally be administered 15-30 minutes before meals to achieve optimal postprandial glucose control, rather than immediately before eating. 2 Research in diabetic children demonstrated that injecting regular insulin 30 minutes before breakfast resulted in consistently lower postprandial blood glucose concentrations compared to injection 5 minutes before the meal, with the greatest difference (3.7 mmol/L) occurring 150 minutes after breakfast. 2

Comparison to Rapid-Acting Analogues

Actrapid has significantly slower pharmacokinetics compared to modern rapid-acting insulin analogues (such as lispro and aspart), which have:

  • Onset: 5 minutes 1
  • Peak: 1-2 hours 1
  • Duration: 3-4 hours 1

This means rapid-acting analogues provide better postprandial glucose control and can be administered immediately before meals, whereas Actrapid requires advance planning. 3, 4

Important Caveats

Mixing with Other Insulins

When Actrapid is mixed with intermediate-acting insulins (such as NPH/Monotard), its absorption rate may be slightly delayed. 5 Studies show that the incremental area of free insulin up to 90 minutes after administration was lower when regular insulin was mixed with intermediate-acting insulin (21 ± 3 vs. 32 ± 5 microU × ml⁻¹ × min⁻¹), though this difference may not be clinically significant in practice. 5

Hypoglycemia Risk

The extended duration of action (6-8 hours) creates a higher risk of late postprandial hypoglycemia compared to rapid-acting analogues, particularly if meals are delayed or physical activity increases during this period. 1 Patients must be counseled to eat at consistent intervals when using regular insulin to avoid hypoglycemia during the extended tail of insulin action. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.